About This Webinar
End Stage Kidney Disease (ESKD) is a rapidly growing healthcare and economic crisis that has failed to elicit a response of adequate proportion. Approximately 800,000 patients live with ESKD, and almost 150,000 new patients/year are diagnosed with ESKD. ESKD patients make up 1% of the Medicare population but account for 7.2% of Medicare spending, or $37B. These statistics demonstrate ESKD patient care is a costly challenge without commensurate evolution in policy, infrastructure, and innovation.
Intermittent monitoring is not enough. The lack of continuity of care results in $14B/year spent on preventable dialysis-related hospitalizations. Without continuous monitoring, care teams are unable to intervene in a timely manner, resulting in costly complications:
- 40% of dialysis patients are hospitalized for fluid overload
- 65% of dialysis hospitalizations are due to preventable vascular access and fluid management issues
- Dialysis patients spend an average of 10 days/year in the ICU
ESKD hospitalization rates have increased over the last few years, standing in contrast to the broader Medicare population with decreased hospital discharge rates.
Health systems are able to continuously monitor dialysis patients in and out of the clinic through remote patient monitoring technology. Key requirements include ensuring the data is of clinical grade, insights are actionable, and technology is noninvasive, unintrusive and easy to use.
Rethinking the reimbursement and regulatory landscape to create greater access to innovation and encourage widespread public-private partnerships and value-based care will ultimately improve lives and health outcomes of ESKD patients while driving down costs.
The webinar will review and discuss:
- The scope and scale of the challenges facing the ESKD population
- The evolving reimbursement landscape - expand on paying for RPM, RTM and AI technologies
- Innovation in the medical technology sector that address the current challenges in the health care system – to prevent hospitalizations and improve patients’ lives
- Progress on eliminating barriers and creating the momentum necessary for scalable systemic change, such as the CURES Act and KidneyX
Attendees Will Learn About
- How to navigate the latest policy (Medicare Advantage) changes that impact ESKD patients
- Three meaningful shifts we can make to catalyze change for both the health system and patients alike
- Reshaping the reimbursement landscape
- Expanding pathways for patients to access and get coverage for innovative technologies
- Fostering partnerships between the public and private sector
